pharma · Elderly AML Patients · Menkes Syndrome
Kunming Hope of
Kunming Hope of Health Hospital
Kunming Hope of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Elderly AML Patients, Menkes Syndrome. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent rec
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 8
- Patents
- 0
Recombinant adeno-associated virus administration
Phase 1 · small molecule · Menkes Syndrome
Recombinant adeno-associated virus administration for Menkes Syndrome is a Phase 1 program (small_molecule) at Kunming Hope of Health Hospital with 1 ClinicalTrials.gov record(s).
Internal code HOPE-1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Kunming Hope of Health Hospital
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Menkes Syndrome
- Status
- terminated
- Trials
- 1